Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

Lung cancer is diagnosed by taking a biopsy from the suspicious area of the lung, which can be done with both bronchoscopy ...

OU Health marked a significant breakthrough for Oklahoma in lung cancer treatment, becoming the first health care system in ...

It’s possible to catch a cold or get the flu at any time of year. But the chances of becoming sick increase during cold and ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

Medically reviewed by Susan Russell, MDLung cancer prognosis tends to be better for people diagnosed in earlier stages of the ...

This study investigated patients with primary lung cancer who received PET/CT scan, a medical imaging test, and subsequently ...

Medically reviewed by Marla Anderson, MD Lung cancer causes cancer cells to develop a tumor in the lungs' tissues. Lung ...

They received treatment between April 2017 and September ... metabolic profile as potential prognostic factors in metastatic lung cancer patients, European Journal of Clinical Investigation ...